AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
7.49
-0.46 (-5.79%)
At close: Oct 30, 2026, 4:00 PM EDT
7.40
-0.09 (-1.20%)
After-hours: Oct 30, 2026, 7:30 PM EDT
AgomAb Therapeutics NV Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $28 | Buy | Maintains | $28 | +273.83% | Oct 26, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $35 | Buy | Reiterates | $35 | +367.29% | Oct 20, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $60 | Buy | Maintains | $60 | +701.07% | Oct 14, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Reiterates $36 | Buy | Reiterates | $36 | +380.64% | Oct 2, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 15, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $13 → $17 | Buy | Initiates | $13 → $17 | +126.97% | Aug 19, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Initiates $34 | Buy | Initiates | $34 | +353.94% | Jul 23, 2026 |